218 related articles for article (PubMed ID: 29398519)
21. Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling.
Kickstein E; Krauss S; Thornhill P; Rutschow D; Zeller R; Sharkey J; Williamson R; Fuchs M; Köhler A; Glossmann H; Schneider R; Sutherland C; Schweiger S
Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21830-5. PubMed ID: 21098287
[TBL] [Abstract][Full Text] [Related]
22. Wogonin increases β-amyloid clearance and inhibits tau phosphorylation via inhibition of mammalian target of rapamycin: potential drug to treat Alzheimer's disease.
Zhu Y; Wang J
Neurol Sci; 2015 Jul; 36(7):1181-8. PubMed ID: 25596147
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of Wnt and PI3K signaling modulates GSK-3beta activity and induces morphological changes in cortical neurons: role of tau phosphorylation.
Mercado-Gómez O; Hernández-Fonseca K; Villavicencio-Queijeiro A; Massieu L; Chimal-Monroy J; Arias C
Neurochem Res; 2008 Aug; 33(8):1599-609. PubMed ID: 18461448
[TBL] [Abstract][Full Text] [Related]
24. Glutamate treatment and p25 transfection increase Cdk5 mediated tau phosphorylation in SH-SY5Y cells.
Jämsä A; Bäckström A; Gustafsson E; Dehvari N; Hiller G; Cowburn RF; Vasänge M
Biochem Biophys Res Commun; 2006 Jun; 345(1):324-31. PubMed ID: 16678793
[TBL] [Abstract][Full Text] [Related]
25. SLM, a novel carbazole-based fluorophore attenuates okadaic acid-induced tau hyperphosphorylation via down-regulating GSK-3β activity in SH-SY5Y cells.
Wu X; Kosaraju J; Tam KY
Eur J Pharm Sci; 2017 Dec; 110():101-108. PubMed ID: 28359686
[TBL] [Abstract][Full Text] [Related]
26. Implication of phosphatidylinositol-3 kinase/Akt/glycogen synthase kinase-3β pathway in ginsenoside Rb1's attenuation of beta-amyloid-induced neurotoxicity and tau phosphorylation.
Zhao R; Zhang Z; Song Y; Wang D; Qi J; Wen S
J Ethnopharmacol; 2011 Feb; 133(3):1109-16. PubMed ID: 21129477
[TBL] [Abstract][Full Text] [Related]
27. Effects of PTEN inhibition on regulation of tau phosphorylation in an okadaic acid-induced neurodegeneration model.
Chen Z; Chen B; Xu WF; Liu RF; Yang J; Yu CX
Int J Dev Neurosci; 2012 Oct; 30(6):411-9. PubMed ID: 22906543
[TBL] [Abstract][Full Text] [Related]
28. Role of protein phosphatase-2A and -1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain.
Bennecib M; Gong CX; Grundke-Iqbal I; Iqbal K
FEBS Lett; 2000 Nov; 485(1):87-93. PubMed ID: 11086171
[TBL] [Abstract][Full Text] [Related]
29. Cross talk between PI3K-AKT-GSK-3β and PP2A pathways determines tau hyperphosphorylation.
Wang Y; Yang R; Gu J; Yin X; Jin N; Xie S; Wang Y; Chang H; Qian W; Shi J; Iqbal K; Gong CX; Cheng C; Liu F
Neurobiol Aging; 2015 Jan; 36(1):188-200. PubMed ID: 25219467
[TBL] [Abstract][Full Text] [Related]
30. The impact of tau hyperphosphorylation at Ser
Majd S; Power JHT; Koblar SA; Grantham HJM
IBRO Rep; 2017 Jun; 2():1-13. PubMed ID: 30135928
[TBL] [Abstract][Full Text] [Related]
31. Troglitazone, a thiazolidinedione, decreases tau phosphorylation through the inhibition of cyclin-dependent kinase 5 activity in SH-SY5Y neuroblastoma cells and primary neurons.
Cho DH; Lee EJ; Kwon KJ; Shin CY; Song KH; Park JH; Jo I; Han SH
J Neurochem; 2013 Sep; 126(5):685-95. PubMed ID: 23581463
[TBL] [Abstract][Full Text] [Related]
32. Activation of the 5'-AMP-Activated Protein Kinase in the Cerebral Cortex of Young Senescence-Accelerated P8 Mice and Association with GSK3β- and PP2A-Dependent Inhibition of p-tau₃₉₆ Expression.
Kim HS; Moon S; Paik JH; Shin DW; Kim LS; Park CS; Ha J; Kang JH
J Alzheimers Dis; 2015; 46(1):249-59. PubMed ID: 25737046
[TBL] [Abstract][Full Text] [Related]
33. MiR-124-3p attenuates hyperphosphorylation of Tau protein-induced apoptosis via caveolin-1-PI3K/Akt/GSK3β pathway in N2a/APP695swe cells.
Kang Q; Xiang Y; Li D; Liang J; Zhang X; Zhou F; Qiao M; Nie Y; He Y; Cheng J; Dai Y; Li Y
Oncotarget; 2017 Apr; 8(15):24314-24326. PubMed ID: 28186985
[TBL] [Abstract][Full Text] [Related]
34. The new indirubin derivative inhibitors of glycogen synthase kinase-3, 6-BIDECO and 6-BIMYEO, prevent tau phosphorylation and apoptosis induced by the inhibition of protein phosphatase-2A by okadaic acid in cultured neurons.
Martin L; Magnaudeix A; Wilson CM; Yardin C; Terro F
J Neurosci Res; 2011 Nov; 89(11):1802-11. PubMed ID: 21826701
[TBL] [Abstract][Full Text] [Related]
35. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
36. Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory.
Liu SJ; Zhang AH; Li HL; Wang Q; Deng HM; Netzer WJ; Xu H; Wang JZ
J Neurochem; 2003 Dec; 87(6):1333-44. PubMed ID: 14713290
[TBL] [Abstract][Full Text] [Related]
37. Complement C3a receptor antagonist attenuates tau hyperphosphorylation via glycogen synthase kinase 3β signaling pathways.
Hu J; Yang Y; Wang M; Yao Y; Chang Y; He Q; Ma R; Li G
Eur J Pharmacol; 2019 May; 850():135-140. PubMed ID: 30771350
[TBL] [Abstract][Full Text] [Related]
38. Nav1.7 sodium channel-induced Ca2+ influx decreases tau phosphorylation via glycogen synthase kinase-3beta in adrenal chromaffin cells.
Kanai T; Nemoto T; Yanagita T; Maruta T; Satoh S; Yoshikawa N; Wada A
Neurochem Int; 2009 Jul; 54(8):497-505. PubMed ID: 19428794
[TBL] [Abstract][Full Text] [Related]
39. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.
Wang JZ; Grundke-Iqbal I; Iqbal K
Eur J Neurosci; 2007 Jan; 25(1):59-68. PubMed ID: 17241267
[TBL] [Abstract][Full Text] [Related]
40. Microcystin-Leucine-Arginine Induces Tau Pathology Through Bα Degradation via Protein Phosphatase 2A Demethylation and Associated Glycogen Synthase Kinase-3β Phosphorylation.
Zhang Y; Zhang J; Wang E; Qian W; Fan Y; Feng Y; Yin H; Li Y; Wang Y; Yuan T
Toxicol Sci; 2018 Apr; 162(2):475-487. PubMed ID: 29228318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
